Get the Stockscreener App
381.79
3.58%
13.18
After Hours:
382.90
1.11
+0.29%
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $381.79, with a volume of 1.48M.
It is up +3.58% in the last 24 hours and up +2.44% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$368.61
Open:
$372.07
24h Volume:
1.48M
Relative Volume:
1.25
Market Cap:
$145.54B
Revenue:
$21.97B
Net Income/Loss:
$3.59B
P/E Ratio:
40.92
EPS:
9.33
Net Cash Flow:
$3.21B
1W Performance:
+4.86%
1M Performance:
+2.44%
6M Performance:
+14.50%
1Y Performance:
+21.48%
1-Day Range:
$372.07
$381.82
1-Week Range:
$359.32
$381.82
52-Week Range:
$307.23
$398.20
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
381.79 | 145.54B | 21.97B | 3.59B | 3.21B | 9.33 |
|
ABT
Abbott Laboratories
|
113.91 | 197.57B | 41.22B | 5.77B | 6.49B | 3.29 |
|
BSX
Boston Scientific Corp
|
98.17 | 144.69B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
87.16 | 111.76B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.86 | 41.20B | 6.60B | 4.16B | 490.10M | 6.93 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Surgical Gown Market is Set to Grow at a 5.4% CAGR, Projected to Reach US$ 2,734.7 Million by 2034 | Fact.MR Report - GlobeNewswire Inc.
Godsey & Gibb Inc. Has $23.96 Million Stake in Stryker Co. (NYSE:SYK) - MarketBeat
Stryker Corp. stock rises Wednesday, still underperforms market - MarketWatch
Stryker Corporation (SYK): A Bull Case Theory - MSN
Campbell Newman Asset Management Inc. Sells 8,047 Shares of Stryker Co. (NYSE:SYK) - MarketBeat
Stryker Co. (NYSE:SYK) Position Lifted by Thurston Springer Miller Herd & Titak Inc. - MarketBeat
CCLA Investment Management Has $113.10 Million Stock Holdings in Stryker Co. (NYSE:SYK) - MarketBeat
Plasma Resectoscope Market Projected To Witness Substantial Growth, 2024-2031: Olympus Corporation, Stryker - EIN News
Stryker Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Dale Q Rice Investment Management Ltd Makes New Investment in Stryker Co. (NYSE:SYK) - MarketBeat
Stryker agrees to acquire Inari Medical for $4.9bn - MSN
Aneurysm Coiling and Embolization Devices Market to Grow by USD 2.0 Billion from 2025-2029, Driven by Rising IAS Cases and AI-Powered Market EvolutionTechnavio - The Malaysian Reserve
3,750 Shares in Stryker Co. (NYSE:SYK) Acquired by PFW Advisors LLC - MarketBeat
Stryker to Acquire Inari Medical for $4.9B - Orange County Business Journal
Here’s Why Jim Cramer Is Excited About Stryker (SYK) Expanding Beyond Surgical Robotics - MSN
Fiduciary Alliance LLC Invests $2.49 Million in Stryker Co. (NYSE:SYK) - MarketBeat
Clark & Stuart Inc Buys New Position in Stryker Co. (NYSE:SYK) - MarketBeat
Stryker Corporation: Inside the Business Model of a MedTech Leader - substack.com
Czech National Bank Has $26.80 Million Stake in Stryker Co. (NYSE:SYK) - MarketBeat
Stryker to Buy Inari Medical in $4.9 Billion Deal - MSN
Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio? - Benzinga
Stryker Stock Falls Despite the Agreement to Acquire Inari Medical - MSN
International Assets Investment Management LLC Sells 851,186 Shares of Stryker Co. (NYSE:SYK) - MarketBeat
Earnings Preview: What To Expect From Stryker’s Report - Barchart
Stryker (NYSE:SYK) Upgraded by StockNews.com to Buy Rating - MarketBeat
Bunion correction systems Market Key Players AnalysisStryker - openPR
Stryker Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
StrykerStarting 2025 With A Bolt-On Deal For Inari Medical (NYSE:SYK) - Seeking Alpha
Rempart Asset Management Inc. Increases Stock Holdings in Stryker Co. (NYSE:SYK) - MarketBeat
Heart device impresses FDA | Stryker acquires Inari Medical for $4.9B | CES 2025 | Limiting TAVR complications - Cardiovascular Business
Hysteroscopy Instruments Market Research 2024-2028 & 2033 Featuring Major PlayersMedtronic, Fujifilm, Stryker, Boston Scientific, and B. Braun Melsungen - Yahoo Finance UK
Park National Corp OH Decreases Holdings in Stryker Co. (NYSE:SYK) - MarketBeat
Stryker’s Strategic Acquisition of Inari Medical Announced - Yahoo Finance
Stryker Corporation (SYK) Announces Merger Agreement with Inari Medical - GuruFocus.com
Stryker's SWOT analysis: stock poised for growth amid acquisition and innovation - Investing.com
Device maker Stryker in US$4.9bil deal for Inari - The Star Online
Stryker strikes early in 2025 with nearly $5B deal for Inari - BioWorld Online
Stryker Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Inari Medical Catapults — Again — After Stryker Confirms $4.9 Billion Deal - Yahoo! Voices
Stryker To Buy Inari Medical In $4.9 Billion Deal - Pulse 2.0
Stryker Acquires Inari Medical in a $4.9 Billion All-Cash Deal - GuruFocus.com
Penumbra stock rises following Stryker's Inari Medical acquisition By Investing.com - Investing.com South Africa
Penumbra stock rises following Stryker's Inari Medical acquisition - Investing.com
Stryker acquires Inari Medical for $4.9B - Cardiovascular Business
Penumbra spikes after Stryker- Inari deal - MSN
Stryker inks $4.9B deal for blood clot buster Inari Medical - Fierce Biotech
Stryker's $4.9B Power Move: Why This MedTech Giant Just Changed the Game - Yahoo Finance
Inari Getting Acquired by Stryker for $4.9B - Orange County Business Journal
Stryker to acquire Inari Medical for $4.9B - Modern Healthcare
Penumbra stock gains after Stryker- Inari deal (NARI:NASDAQ) - Seeking Alpha
Stryker stock reiterates Buy rating on acquisition plan - Investing.com India
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.32%
0.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):